Wells Fargo’s Aerie Pharmaceuticals AERI Stock Holding History

Wells Fargo’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$183K	–	6596
2018 Q4	$183K	Hold	20,000	–	–	﹤0.01%	4974
2018 Q3	$23K	Hold	20,000	–	–	﹤0.01%	5802
2018 Q2	$47K	Hold	20,000	–	–	﹤0.01%	5610
2018 Q1	$96K	Hold	20,000	–	–	﹤0.01%	5325
2017 Q4	$87K	Buy	+20,000	New	+$1.21M	﹤0.01%	5366

Wells Fargo's AERI Position: Q4 2022 in Review

Wells Fargo sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 169,586 shares — an estimated $2.57M sold.

Wells Fargo first reported a position in AERI in Q1 2014 and held it in 35 quarters. The position peaked at $2.57M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Wells Fargo reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Wells Fargo sold 169,586 Aerie Pharmaceuticals shares in Q4 2022, an estimated $2.57M.
Wells Fargo first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 35 quarters.
Wells Fargo's Aerie Pharmaceuticals position peaked at $2.57M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.